Alberto Del Rio Selected Research

Alberto Del Rio Research Topics

Disease

18	Neoplasms (Cancer) 11/2023 - 12/2012
5	Breast Neoplasms (Breast Cancer) 11/2023 - 06/2011
3	Carcinogenesis 10/2023 - 01/2013
3	Inflammation (Inflammations) 06/2014 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017 - 09/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 10/2015 - 12/2012
2	Genomic Instability 08/2015 - 06/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023
1	Chronic Disease (Chronic Diseases) 07/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 04/2016
1	Skin Neoplasms (Skin Cancer) 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2015
1	Down Syndrome (Down's Syndrome) 02/2015
1	Acute Promyelocytic Leukemia 08/2014
1	Ischemia 01/2013
1	Immune System Diseases (Immune Disorders) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Central Nervous System Diseases (CNS Diseases) 01/2013
1	Acute Lung Injury 01/2013

Drug/Important Bio-Agent (IBA)

6	NAD (NADH)IBA 07/2022 - 06/2014
5	SirtuinsIBA 10/2023 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2013
5	EnzymesIBA 07/2022 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2015
2	Cadherins (E-Cadherin)IBA 10/2023 - 12/2022
2	MethyltransferasesIBA 12/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 12/2022 - 10/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 09/2015
2	Gemcitabine FDA Link 10/2017 - 09/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
2	Aromatase InhibitorsIBA 01/2016 - 06/2011
2	MicroRNAs (MicroRNA)IBA 08/2014 - 01/2013
1	ZinostatinIBA 11/2023
1	VimentinIBA 10/2023
1	Keratin-8 (Keratin 8)IBA 10/2023
1	Keratin-6 (Keratin 6A)IBA 10/2023
1	ElementsIBA 07/2023
1	Fibronectins (Fibronectin)IBA 12/2022
1	Cyclin-Dependent Kinase 2IBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	nicotinate phosphoribosyltransferaseIBA 07/2022
1	2-hydroxynicotinic acidIBA 07/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	SalicylatesIBA 10/2017
1	Trastuzumab (Herceptin)FDA Link 04/2016
1	Hormones (Hormone)IBA 01/2016
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2015
1	Histone-Lysine N-MethyltransferaseIBA 10/2015
1	olaparibIBA 09/2015
1	QuinazolinonesIBA 09/2015
1	Cytotoxins (Cytolysins)IBA 09/2015
1	Protein Isoforms (Isoforms)IBA 08/2015
1	Pyruvate KinaseIBA 08/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2015
1	Apoptosis Regulatory ProteinsIBA 08/2015
1	A-Form DNA (A-DNA)IBA 02/2015
1	enzalutamideIBA 09/2014
1	Androgen Receptors (Androgen Receptor)IBA 09/2014
1	VA 061 (VA061)IBA 09/2014
1	bicalutamide (Casodex)FDA LinkGeneric 09/2014
1	AndrogensIBA 09/2014
1	Small Interfering RNA (siRNA)IBA 08/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013
1	Sirtuin 2IBA 01/2013
1	Sirtuin 3IBA 01/2013
1	Neutralizing AntibodiesIBA 01/2013
1	Chemotactic FactorsIBA 01/2013
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2013
1	Sirtuin 1IBA 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 12/2012
1	Protein Kinase InhibitorsIBA 12/2012
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 12/2012
1	Estrogens (Estrogen)FDA Link 06/2011

Therapy/Procedure

5	Therapeutics 07/2022 - 01/2013
1	Precision Medicine 01/2022
1	Photothermal Therapy 01/2019
1	Radiotherapy 10/2017
1	Castration 09/2014